May the Drug Transporter P Glycoprotein Affect the Antiviral Activity of Human Immunodeficiency Virus Type 1 Proteinase Inhibitors?
AUTOR(ES)
Turriziani, Ombretta
FONTE
American Society for Microbiology (ASM)
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=89711Documentos Relacionados
- Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
- Antiviral Activity of the Proteasome on Incoming Human Immunodeficiency Virus Type 1
- Kinetics of Antiviral Activity and Intracellular Pharmacokinetics of Human Immunodeficiency Virus Type 1 Protease Inhibitors in Tissue Culture
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.
- Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease.